2011 Speakers

• Anita Pascarella-Hallet, Director, Clinical Diagnostic Services, Eli Lilly
• Asita de Silva, MBBS, DPhil, Director, Clinical Trials Unit, Faculty of Medicine, University of Kelaniya, Sri Lanka
• Alaine Bouckenooghe, Head, Clinical Development R&D, Regional/Asia Pacific, Sanofi Aventis Singapore
• Allan Riting Liu, Vice President, Fosun Pharmaceutical
• Bradley Marchant, Head of Clinical Development Asia, Sanofi Aventis, China
• Carl Firth, Chief Executive Officer, Aslan Pharmaceuticals, Singapore Chichang Lee, Executive Director, Simcere Pharmaceuticals, China
• Chichang Lee, Executive Director, Simcere
• Chris Chen, Chief Executive Officer, Shanghai Celgen Biopharmaceuticals, China
• Christina Bodurow, PhD, Senior Director, External Sourcing Development Center of Excellence, Eli Lilly and Company
• Darshan Bhatt, MD, M.Phil. Director Clinical Drug Safety, Vanthys Pharmaceutical Development , USA
• David Selkrik, Independent Consultant Selkrik & Co.
• Donald Russell, Sr Director, Intl Clinical Operations, Eli Lilly and Company
• Emily Tan, Executive Director, Pharmanet
• Fred Zheng, MD., Ph.D. Research Clinical Scientist, AstraZeneca
• Helen Jiang, Vice President Clinical, Hengrui Pharmaceuticals, China
• Hiroshi Sugii, Vice President Clinical Development, Novo Nordisk, Japan
• James Cai, Vice President for Clinical Development, Atyr Pharma, China
• James Philip Cruz, Senior Medical Manager, GSK Biologicals
• James Tsui, Contracts & Outsourcing, Roche Product Development Asia Pacific, China
• Janelle A. Sabo, PharmD, RPh, CA-AM, , Sr. Director, Global Clinical Trials Materials Services (CTMS), Eli Lilly
• Jennifer Sung, Executive Director, Novartis, China
• Jenny Zhang, MSc., MBA, Vice President, Global Laboratory Operations and Asia, Clearstone Central Laboratories, a LabCorp Company
• Jingzong Oi, PhD, VP & Director of Business Development, FusoGen Pharmaceuticals, Inc.
• Joan Shen, MD, PhD, Senior Medical Director Clinical Research, Primary Care Unit, Pfizer Inc
• Joe Zhou, Chief Executive Officer, Genor BioPharma, China
• John Constantine, Executive Director, Head Merck Polytechnic Institute
  
• John Hubbard, SVP Global Drug Development, Pfizer Inc, USA
• Jimmy Bautista, Regional Medical Director, Eisai Asia, China
• Li Ding, Head of Trial Operations- China and APAC, Clinical Science and Operations, Sanofi Aventis, China
• Ling Su, Senior Vice President & Head of Development Greater China, Novartis Pharmaceuticals, China
• Matthew J. Bryant, Sr. Manager, Oncology Asia Pacific Clinical Project Management, DCOE AP - Eli Lilly Japan
• Lee S Scheible, Medical Consultant, Eli Lilly and Company
• Malcolm Burgess, Executive Vice President, ICON Clinical Research, Hong Kong
  
• Melvin Toh, Vice President Pharma Development, CK Life Sciences, Hong Kong
• Michael Rozycki , VP Regulatory Affairs Asia Pacific, Allergan, China
• Nadina C Jose, Regional Director, Global Clinical Site Management and Monitoring Asia-Pacific, Allergan, Singapore
• Pratik Shah, Head of Clinical Research and Development, Astellas Pharma, India
• Rebecca Wang, Head of Product Safety Operation- Asia Pacific, Roche, China Ross Horsburgh, Vice President Clinical Development, Nycomed, Singapore
• Roshan Padbidri, SM, Clinical Operations, Takeda Global Research & Development Center (Asia)
• Ross Horsburgh, Vice President Clinical Development, Nycomed, Singapore
• Rudi Ladenius,PhD, Senior Director, Global Research Operations PAREXEL International (Asia)
• Rupesh Patki, Associate Director, Global Clinical Site Management and Monitoring, Allergan Singapore Pte. Ltd
• Sally Sha, Business Development Project Director, Tigermed, China
• Scott Liu, Chief Executive Officer, Henlius Biopharma, China
• Shirley Zhao, General Manager, Genzyme China
• Stephen Porter, CEO, VDDI Pharmaceuticals, USA
• Steven Bukvic, Chairman and Founding Director, PACRA
• Vance Warren, Senior Study Logistics Manager Translational Medicine Clinical Pharmacology, Daiichi Sankyo Pharma Development
• Tadashi Fujisawa, Chief Executive Officer, Mebiopharm, Japan
• Vincengo Teneggi, Head of Early Development & Clinical Pharmacology, Asia Pacific, Roche R&D Center (China) Ltd
• Wenmin Du, Executive Director, SFDA, China
• Xin Li, President, Sun Wei Biotech, China
• Xingiang Li, CEO, Sun Wei Therapeutics (SUZHOU), Inc
• Xue Chen, Head of Clinical Services and Operations in China, Sanofi-Aventis
• Yutaka Natsumeda, Director of Office of Clinical Trials, Yokohama City University Hospital, Japan
• Yuqiang Wang, Chief Executive Officer, Magpie Biotech, China

2011 ADVISORY BOARD

• Al Palaniappan, Head of Outsourcing and Business Operations, R&D China, GlaxoSmithKline
• Ann Wang, Vice President, Clinical Operations and Data Management, Human Genome Sciences, USA
• Christina Bodurow, Ph.D, Senior Director, External Sourcing Development Center of Excellence, Eli Lilly
• Christopher Albani, Managing Director, PRTM JAPAN
• Dan Weng, Vice President, Rest of World, MedPace
• Darshan Bhatt, MD, MPhil, Director Clinical Drug Safety, Vanthys Pharmaceutical Development (P) Ltd
• Fidela Moreno, MD, Vice President, Global Development Operations, Clinical Site Management and Monitoring, Allergan Inc., USA
• James Cai, VP, Clinical Development, aTyr Pharma
• James Garner, MD, Vice President & General Manager, Takeda Clinical Research, Singapore
• Joan Shen, MD, PhD, Senior Medical Director Clinical Research, Primary Care Unit, Pfizer Inc.
• Julia Zhang, Associate Director, Standard Program Manager
• Kieko Oishi, Representative Managing Director, Corporate Officer International Business and Corporate Development, CMIC Co., Ltd.
• Lawrence Fiori, Associate Director, Clinical Trial Outsourcing & Compliance, Compliance and Quality Management, Boehringer Ingelheim, USA
• Mark Bach, PhD, Vice President, Head of R&D, Regulatory Affairs and Safety, Janssen Pharmaceuticals KK, Japan
• Professor Asita de Silva, MBBS, DPhil Director, Clinical Trials Unit, Faculty of Medicine, University of Kelaniya
• Nadina Jose, MD, CPI (Hon)/ Regional Director, Global Clinical Site Management and Monitoring Asia-Pacific, Allergan Pte. Ltd
• Radhika Bobba, Partner, Anhvita BioPharma Consulting
• Rajeev Shrivastava Associate Director-Clinical Research Eli Lilly and Company (India) Pvt. Ltd.
• Robert Teoh, Managing Director, Pacific Clinical Research
• Roshan Padbiri SM - Clinical Operations Takeda Global Research & Development Center (Asia) Pte Ltd
• Songlin Xue, SVP, Drug Safety and Risk Management, Takeda Pharmaceuticals
• Stephen Porter, Pharm.D., FCP, MRCP Chairman, President and CEO, VDDI Pharmaceuticals
• Stephen Doyle, VP Oncology BU, China, Sanofi Aventis
• Yan Wu, Medical Director, Biogen Idec